obinutuzumab and venetoclax for high-risk cll: upcoming cll14 trial
Published 7 years ago • 230 plays • Length 0:45
Download video MP4
Download video MP3
Similar videos
-
2:00
obinutuzumab, ibrutinib, and venetoclax in high-risk cll: the cll2-give and cll13 trials
-
5:54
cll14: venetoclax plus obinutuzumab for cll
-
0:59
5-year follow-up results of cll14: obinutuzumab venetoclax vs obinutuzumab chlorambucil in cll
-
1:43
six-year update from cll14: fixed-duration venetoclax obinutuzumab for previously untreated cll
-
1:24
venetoclax plus obinutuzumab in ckt cll: analysis from the cll14 trial
-
4:30
cll14 trial: obinutuzumab venetoclax vs obinutuzumab chlorambucil
-
5:59
6-year results of cll14: venetoclax-obinutuzumab for previously untreated cll
-
7:29
venetoclax obinutuzumab: impact on cll management
-
9:15
obinutuzumab venetoclax for frontline cll
-
12:05
venetoclax combinations, safety and efficacy
-
0:48
venetoclax and obinutuzumab for cll
-
1:16
cll14: venetoclax-obinutuzumab improves pfs and mrd in untreated, reduced fitness cll
-
6:34
3-year follow-up of obinutuzumab, ibrutinib and venetoclax for cll
-
2:03
venetoclax and obinutuzumab combination therapy for cll
-
1:42
patients with cll and partial response to venetoclax-obinutuzumab
-
10:24
fixed-duration therapy with venetoclax-obinutuzumab in frontline cll
-
1:35
cll: venetoclax in combination with obinutuzumab
-
1:59
acalabrutinib, venetoclax and obinutuzumab upfront for cll
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
3:22
combining venetoclax and obinutuzumab in the treatment of cll
-
1:09
majic: venetoclax with acalabrutinib or obinutuzumab in cll
-
1:46
novel agent combinations for cll: ibrutinib, venetoclax, obinutuzumab and zanubrutinib
Clip.africa.com - Privacy-policy